Shaily Engineering Plastics

Shaily Engineering Plastics share price has fallen 24% in three months and has dropped 7% in six months. However, the smallcap stock has risen 32% in one year, and has delivered multibagger returns of 283% in two years.

Shaily Engineering Plastics Ltd and Gland Pharma Ltd, involved in the making and filling of injectable pens for semaglutide, stand to win big as patients will need these devices irrespective of which brand of the drug they choose.

UBS has initiated coverage of Shaily Engineering Plastics with a 'Buy' rating and a target price of ₹ 4,000, indicating a 60% upside. The firm highlights Shaily's patented technology and strong market position for GLP-1 therapies, estimating substantial revenue growth and a 75% EPS CAGR by FY28.

As of September 2025, Ashish Kacholia’s portfolio comprises 42 stocks valued at around ₹ 2,088 crore, with the largest holding in Shaily Engineering Plastics, where he owns 14.79 lakh shares, representing a 3.22% stake valued at ₹ 366.2 crore.

Sumeet Bagadia recommends five breakout stocks to buy today: KRN Heat Exchanger and Refrigeration, Avantel, Shaily Engineering Plastics, Datamatics Global Services, and Fedbank Financial Services.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — R R Kabel, Sudarshan Chemical Industries, Shaily Engineering Plastics, Wockhardt, and Prudent Corporate Advisory Services.

Sumeet Bagadia recommended buying these seven breakout shares to buy today - Shaily Engineering Plastics, Bajaj Healthcare, Cholamandalam Financial Holdings, Kiri Industries, and V2 Retail.

Shaily Engineering Plastics has emerged as a top multibagger stock, delivering remarkable returns of 910% over four years and 15,400% over 11 years. The company focuses on customized plastic components for various industries, with significant growth in its healthcare segment.